Baird Medical Investment Holdings Ltd (BDMD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Baird Medical Investment Holdings Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Baird Medical Investment Holdings Ltd (BDMD) has returned 44.12% so far this year and -62.38% over the past 12 months.

Based on dividend-adjusted daily data since Oct 1, 2024, BDMD's average daily return is +1.23%, while the average monthly return is +8.16%. At this rate, your investment would double in approximately 0.7 years.

Historically, 33% of months were positive and 67% were negative. The best month was Dec 2024 with a return of +210.2%, while the worst month was Oct 2024 at -70.6%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 3 months.

On a daily basis, BDMD closed higher 40% of trading days. The best single day was Dec 31, 2024 with a return of +623.8%, while the worst single day was Dec 30, 2024 at -39.0%.

Baird Medical Investment Holdings Ltd has an annualized alpha of 2064.05%, beta of 0.00, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 02, 2024.

• This stock tended to rise when S&P 500 Index fell (downside capture of -248.84%), but participation in market rallies was also limited (-203.28%) — a profile typical of counter-cyclical assets.
• Beta of 0.00 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BDMD ranks 22 for risk / return — below 22% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Baird Medical Investment Holdings Ltd (BDMD) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Baird Medical Investment Holdings Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Baird Medical Investment Holdings Ltd was 93.07%, occurring on Feb 13, 2026. The portfolio has not yet recovered.

The current Baird Medical Investment Holdings Ltd drawdown is 82.36%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Baird Medical Investment Holdings Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Baird Medical Investment Holdings Ltd is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.